MLYS Q1 2026 Earnings Narrowerthanexpected loss as clinicalstage company advances pipeline NVAX Q1 2026 Earnings NarrowerThanExpected Loss Drives Stock Higher Cato Q4 2025 Earnings Loss Widens as Retail Headwinds Persist DNN Q1 2026 Earnings Large EPS Miss but Uranium Outlook Lifts Shares NRX Pharmaceuticals Q1 2026 Earnings Wider Loss Despite No Revenue Stock Advances FMC Q1 2026 Earnings EPS Surpasses Estimates Despite Loss Shares Rise